Armis Advisers’s Medpace MEDP Stock Holding History

Armis Advisers’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-466	Closed	-$277K	–	448
2025 Q3	$277K	Buy	+466	New	+$203K	0.03%	267
2025 Q1	–	Sell	-837	Closed	-$278K	–	438
2024 Q4	$278K	Buy	+837	New	+$284K	0.03%	280

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armis Advisers's MEDP Position: Q4 2025 in Review

Armis Advisers sold out of Medpace (MEDP) in Q4 2025, closing a stake of 466 shares — an estimated $277K sold.

Armis Advisers first reported a position in MEDP in Q4 2024 and held it in 2 quarters. The position peaked at $278K in Q4 2024. 785 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

Armis Advisers reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
Armis Advisers sold 466 Medpace shares in Q4 2025, an estimated $277K.
Armis Advisers first reported a position in Medpace in Q4 2024 and held it in 2 quarters.
Armis Advisers's Medpace position peaked at $278K in Q4 2024.
785 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Armis Advisers's 13F filing for Q4 2025, filed 24 Mar 2026.